期刊文献+

冠脉支架术后再狭窄血管重塑与脂联素、单核细胞趋化因子-1和内皮功能的相关性 被引量:13

Correlation of adiponectin, monocyte chemoattractant protein-1, and endothelial function to vascular remodeling in coronary in-stent restenosis
暂未订购
导出
摘要 目的通过观察冠脉支架术后再狭窄患者冠状动脉重塑指数(RI)与血清脂联素、血浆单核细胞趋化因子-1(MCP-1)和内皮功能的相关性,进而探讨其发生机制。方法测定30例冠脉支架术后再狭窄患者和30例无狭窄患者术后6个月的RI,术前、术后3日和术后6个月的血清脂联素、血浆MCP-1和肱动脉血流介导的内皮依赖性舒张功能(FMD)等指标。结果再狭窄组患者术后3日和6个月的血浆MCP-1水平显著高于术前和同期对照组(P<0.05),术后6个月的RI显著低于同期对照组,术后3日和6个月的FMD和血清脂联素显著低于术前和同期对照组(P<0.05);术后6个月的RI与脂联素和FMD呈显著正相关,与MCP-1呈显著负相关。结论冠脉支架术后再狭窄的发生发展是多因素综合作用的结果。 Objective To investigate the correlation between vascular remodeling index (RI) and serum adiponectin,plasma monocyte chemoattractant protein-1 (MCP-1),endothelial function and evaluate the mechanism of coronary in-stent restenosis.Methods RI 6 months after percutaneous coronary intervention (PCI),serum adiponectin,plasma MCP-1 and flow-mediated dilation (FMD) before and 3 days,6 months after PCI were measured in 30 patients with and 30 without coronary in-stent restenosis.Results Compared with patients without restenosis and those with restenosis before PCI,the patients with coronary in-stent restenosis showed significantly increased plasma MCP-1 3 days and 6 months after PCI (P0.05) and reduced RI 6 months after PCI,serum adiponectin and FMD 3 days and 6 months after PCI (P0.05).RI was positively correlated to serum adiponectin and FMD and inversely to MCP-1.Conclusion The occurrence of coronary in-stent restenosis is the result of the interrelations between multiple factors.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第4期912-914,共3页 Journal of Southern Medical University
关键词 冠脉支架 再狭窄 血管重塑 脂联素 单核细胞趋化因子-1 内皮功能 coronary in-stent restenosis vascular remodeling adiponectin monocyte chemoattractant protein-1 endothelial function
  • 相关文献

参考文献8

  • 1王翔飞,葛均波.支架内再狭窄与药物支架的临床研究现状[J].中国临床医学,2006,13(6):902-905. 被引量:5
  • 2Kibos A, Campeanu A, Tintoiu I. Pathophysiology of coronary artery in-stent restenosis[J 1. Acute Card Care, 2007, 9(2): 111-9.
  • 3王忠,田银君,杨军,卢桂林,李振,罗丽萍,杨云,谭锋,吴金家,段军仓,张望强,任宏强.不同冠状动脉病变程度冠心病患者血浆脂联素水平及其相关性研究[J].临床心血管病杂志,2008,24(2):98-102. 被引量:7
  • 4Bonello L, De Labriolle A, Lemesle G, et al. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice [J]. Arch Cardiovasc Dis, 2009, 102 (2): 143 -51.
  • 5Mizia-Stec K, Gasior Z, Haberka M, et al. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation [ J ]. Kardiol Pol, 2009, 67(1): 9-17.
  • 6Rudic RD, Bucci M, Fulton D, et al. Temporal events underlying arterial remodeling after chronic flow reduction in mice: correlation of structural changes with a deficit in basal nitric oxide synthesis[J]. Circ Res, 2000, 86(11): 1160-6.
  • 7Kitta Y, Takano H, Nakamura T, et al. Low adiponectin levels predict late in-stent restenosis aider bare metal stenting in native coronary artefies[J ]. Int J Cardiol, 2008, 131(1): 78-82.
  • 8Ohtani K, Usui M, Nakano K, et al. Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-sten restenosis in hypercholesterolemic rabbits and monkeys [ J ]. Gene Ther, 2004, 11 (16): 1273-82.

二级参考文献48

  • 1岳霞,吴华,陈新山.炎症与急性冠状动脉综合征的研究进展[J].临床心血管病杂志,2005,21(6):378-380. 被引量:11
  • 2马建林,李新明,王圣,苏哲坦,毛焕元,张家明,王卫,林劲.不稳定型心绞痛患者体内凝血因子Ⅰ的变化及意义[J].临床心血管病杂志,2006,22(2):121-122. 被引量:4
  • 3Teirstein PS,Kuntz RE.New frontiers in interventional cardiology:intravascular radiation to prevent restenosis[J].Circulation,2001,104:2620-2626.
  • 4Waksman R,Weinberger J.Coronary brachytherapy in the drug-eluting stent era:don't bury it alive[J].Circulation,2003,108:386-388.
  • 5Sousa JE,Costa MA,Abizaid A,et al.Sirolimus-eluting stent for the treatment of in-stent restenosis:a quantitative coronary angiography and three-dimensional intravascular ultrasound study[J].Circulation,2003,107:24-27.
  • 6Degertekin M,Regar E,Tanabe K,et al.Sirolimus-eluting stent for treatment of complex in-stent restenosis:the first clinical experience[J].J Am COll Cardiol,2003,41:184-189.
  • 7Degertekin M,Lemos PA,Lee CH,et al.Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and instent restenosis lesions[J].Eur Heart J,2004,25:32-38.
  • 8Fujii K,Mintz GS,Kobayashi Y,et al.Contribution of stent under expansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis[J].Circulation,2004,109:1085-1088.
  • 9Neumann FJ,Desmet W,Grube E,et al.Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement[J].Circulation,2005,111:2107-2111.
  • 10Commeau P,Barragan PT,Roquebert PO,et al.ISR Ⅱ study:a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions[J].Cath eter Cardiovasc Interv,2005,66:158-162.

共引文献10

同被引文献183

引证文献13

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部